James R Murphy's Net Worth
$7.46 Million
Who is James R Murphy?
James R Murphy has an estimated net worth of $7.46 Million. This is based on reported shares across multiple companies, which include CPEX Pharmaceuticals, Inc., and BENTLEY PHARMACEUTICALS INC.
SEC CIK
James R Murphy's CIK is 0001218893
Past Insider Trading and Trends
2008 was James R Murphy's most active year for acquiring shares with 13 total transactions. James R Murphy's most active month to acquire stocks was the month of September. 2008 was James R Murphy's most active year for disposing of shares, totalling 33 transactions. James R Murphy's most active month to dispose stocks was the month of June. 2006 saw James R Murphy paying a total of $946,000.00 for 364,000 shares, this is the most they've acquired in one year. In 2008 James R Murphy cashed out on 1,377,220 shares for a total of $6,921,179.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CPEX Pharmaceuticals, Inc. No price found
InvestorJames R Murphy owns 115,957 units of Common Stock, $0.01 par value. James R Murphy used to own units in Common Stock and Restricted Stock Unit but no longer holds any shares there.acquired a total of 73,067 shares in CPEX Pharmaceuticals, Inc. at a cost of $566,338.08, James also disposed a total of 124,168 shares of CPEX Pharmaceuticals, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -124.17K |
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +154.35% | 70.37K |
$8.05 | $566,338.09 | 115.96K |
Oct 10
| |||
Form 4
| +6.30% | 2.7K |
—
|
—
| 45.59K |
Jul 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BENTLEY PHARMACEUTICALS INC No price found
Chairman and CEOJames R Murphy owns 413,228 units of Common Stock, $.02 par value. James R Murphy used to own units in Common Stock, $0.02 par value but no longer holds any shares there.acquired a total of 647,000 shares in BENTLEY PHARMACEUTICALS INC at a cost of $2,389,290.00, James also disposed a total of 768,987 shares of BENTLEY PHARMACEUTICALS INC equalling to $10,414,802.61.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -441.11K |
$14.82 | -$6,535,765.58 |
0
|
Jul 22
| |||
Form 4
| +2.69% | 11.25K |
—
|
—
| 428.9K |
May 23
| |||
Form 4
| +1.07% | 4.42K |
$11.97 | -$27,818.62 | 417.65K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +24.31% | 80.8K |
$8.86 | -$601,773.04 | 413.23K |
Mar 23
| |||
Form 4
| +35.56% | 87.21K |
$7.71 | -$586,486.20 | 332.43K |
Sep 30
| |||
Form 4
| +94.64% | 119.23K |
$6.99 | -$490,133.45 | 245.22K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +1.61% | 2K |
$11.25 | $22,500.00 | 125.99K |
Jun 7 - Jun 9
| |||
Form 4
| +0.08% | 100 |
$12.20 | $1,220.00 | 123.99K |
May 12
| |||
Form 4
| +0.32% | 400 |
$10.80 | $4,320.00 | 123.89K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
| +40.00% | 200 |
$15.45 | $3,090.00 | 700 |
Oct 6
| |||
Form 4
| +1.23% | 1.5K |
$5.00 | $7,500.00 | 123.49K |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |